口服西地那非治疗勃起功能障碍有效且安全

Oral Sildenafil Demonstrates the Effectiveness and Well Tolerance in the Treatment of Patients with Erectile Dysfunction

勃起功能障碍(erectile dysfunction,ED)为男性常见疾病,其发病率有上升趋势。西地那非是目前治疗ED的一线口服药物,被广泛用于不同地区、不同年龄、不同病因、不同程度以及伴随不同疾病(如心血管疾病、糖尿病、肾病)的ED患者,并显示出良好的疗效和安全性。现对已发表的部分相关文献进行回顾和综述,旨在与广大同仁分享经验,共同提高。

Erectile dysfunction（ED） is a common disease in male populations, and the morbidity is increasing. Currently, sildenafil is the first line oral therapy in the treatment of erectile dysfunction, and widely used by the patients from different areas, who are variable in ages, etiologies and degrees of severity, and by the patients with different diseases such as cardiovascular problems, diabetes mellitus and nephropathy. The drug manifests the effectiveness and well tolerance. In this paper, we review and summarize some relevant articles published to share information with the medical colleagues. Natl J Androl,2005,11 （11） ：877-879